Results 211 to 220 of about 185,548 (298)
Beyond Starch: Towards a Scalable Potato Platform for Molecular Farming
Re‐engineering potato as a biosafe and host‐optimised platform for plant molecular farming by integrating intrinsic biological traits with targeted engineering strategies. ABSTRACT Thirty‐five years after the first recombinant protein was produced in potato and 30 years after clinical trials of edible vaccines from its tubers, the crop is being ...
Izabela Anna Chincinska +2 more
wiley +1 more source
Anti-Leukemic Properties of Curcumin on Acute Lymphoblastic Leukemia: A Systematic Review. [PDF]
Soh TC +5 more
europepmc +1 more source
The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia [PDF]
et al,, Uy, Geoffrey, Yeshurun, Moshe
core +1 more source
Challenges and Advances in the Detection of Leukemic Blasts in Cerebrospinal Fluid in Pediatric Acute Lymphoblastic Leukemia. [PDF]
Hu Z, E S.
europepmc +1 more source
Exposure to artificial light at night (ALAN), particularly at blue wavelengths, disrupts circadian rhythms by suppressing melatonin, thereby increasing cancer susceptibility. This systematic review consolidates evidence linking prolonged ALAN exposure to an elevated risk of breast and prostate tumors.
Gabriel Barboza +4 more
wiley +1 more source
Improving acute lymphoblastic leukemia diagnosis through CBAM-enhanced VGG19 deep learning. [PDF]
Rahman SIU +7 more
europepmc +1 more source
During the 2023–2024 Argentine dengue outbreak, 33 patients with hematological disease showed high complication rates, frequent hospitalization (64%), severe thrombocytopenia (90%), and 6% dengue‐attributable mortality. Transfusion‐associated cases were documented.
Gustavo Adolfo Méndez +16 more
wiley +1 more source
Oral Microbiome Dynamics in Patients with Acute Lymphoblastic Leukemia and Oral Mucositis. [PDF]
Sánchez-Becerra AE +8 more
europepmc +1 more source
Novel Therapeutic Approaches in Pediatric Acute Lymphoblastic Leukemia. [PDF]
Marrapodi MM +9 more
europepmc +1 more source
Abstract Background ABO‐incompatible (ABOi) hematopoietic stem cell transplantation (HSCT) is often associated with ABO discrepancies post‐HSCT. Re‐emergence of the patient's original type post‐HSCT may signal graft loss, disease relapse, recent transfusion, or soluble ABO antigen.
Sheri Hugan, Nada Naiyer, Laura Cooling
wiley +1 more source

